viernes, 16 de noviembre de 2018

United Therapeutics licenses Arena hypertension drug for up to $1.2B

United Therapeutics licenses Arena hypertension drug for up to $1.2B

The Readout

United Therapeutics licenses Arena hypertension drug in a deal worth up to $1.2 billion

By KATE SHERIDAN @sheridan_kate
NOVEMBER 15, 2018
Publicado por en

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)